MRKR — Marker Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $43.65m
- $26.17m
- $9.01m
- 40
- 11
- 43
- 23
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -148 | -21.4 | -28.7 | -41.9 | -29.9 |
Depreciation | |||||
Non-Cash Items | 132 | 5.52 | 5.79 | 6.98 | 5.98 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.04 | -2.48 | 2.4 | 5.47 | -5.81 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -14.5 | -18.3 | -20 | -27.3 | -27 |
Capital Expenditures | -0.148 | -0.375 | -9.25 | -3.13 | -4.95 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.148 | -0.375 | -9.25 | -3.13 | -4.95 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 71.2 | 0.816 | 6.74 | 52.6 | 0.202 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 56.6 | -17.8 | -22.6 | 22.1 | -31.7 |